| Lin, Junzhong |
NCT06018714: Efficacy of Modified Fruquintinib in Colorectal Cancer Liver Metastases: A Phase II Study |
|
|
| Recruiting | 2 | 64 | RoW | Fruquintinib | Sun Yat-sen University | Colorectal Cancer Metastatic | 08/24 | 08/26 | | |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Recruiting | N/A | 3600 | RoW | | Zhejiang University, New Horizon Health Technology Co., Ltd | Colorectal Cancer, Adenomatous Polyps, Adenoma, Advanced Adenoma | 12/26 | 06/27 | | |
NCT05528783: Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance |
|
|
| Recruiting | N/A | 200 | RoW | | Sun Yat-sen University, New Horizon Health | Colorectal Cancer | 11/26 | 01/27 | | |
| Zhang, Weili |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Li, Yuan |
TQB2450-III-07, NCT04523272: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer |
|
|
| Active, not recruiting | 3 | 528 | RoW | TQB2450, Anlotinib, Sunitinib | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Renal Cancer | 06/25 | 12/25 | | |
| Recruiting | 2 | 32 | RoW | Anlotinib, anlotinib hydrochloride, Penpulimab, AK105 | Peking Union Medical College Hospital | Colorectal Cancer | 08/22 | 08/23 | | |
| Recruiting | 2 | 40 | RoW | Tisleizumab(BGB-A317), surgery | Sun Yat-sen University | DMMR Colorectal Cancer, Anti PD-1, Immunotherapy | 11/24 | 12/25 | | |
NCT06014372: Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer |
|
|
| Recruiting | 2 | 55 | RoW | Envafolimab, CAPEOX | Sun Yat-sen University | Colon Cancer, Neoadjuvant Therapy, Immunotherapy | 07/24 | 07/26 | | |
NCT04834544: A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care |
|
|
| Recruiting | 2 | 75 | RoW | DCVAC/OvCa, Placebo | Peking University Third Hospital, Sotio a.s. | Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | 10/24 | 04/27 | | |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
NCT06564428: A Cohort Study of Genetic Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration |
|
|
| Recruiting | N/A | 1000 | RoW | Suspective gene mutations and family history | Peking University Third Hospital | Ovarian Neoplasms | 12/26 | 12/26 | | |
NCT06306677: Accuracy of an AI-clinical Knowledge-based Hybrid System for Detecting Periodontitis in OPG Images |
|
|
| Recruiting | N/A | 1200 | Europe, RoW | AI-clincial-based hybrid system for radiographic image analysis | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, ShanghaiTech University, University of Roma La Sapienza, The University of Hong Kong | Periodontitis, Periodontal Diseases | 08/24 | 12/24 | | |
NCT05227391: Live Birth After Letrozole-stimulated Cycles Versus Hormone Replacement Treatment Cycles for the First Frozen Embryo Transfer in Women With PCOS |
|
|
| Recruiting | N/A | 1078 | RoW | Oral Letrozole, Oral estradiol valerate | Reproductive & Genetic Hospital of CITIC-Xiangya | PCOS | 06/24 | 12/24 | | |
NCT03261934: Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation |
|
|
| Recruiting | N/A | 2000 | RoW | No intervention | Beijing University of Chinese Medicine, The University of Science and Technology of China, China Academy of Chinese Medical Sciences, Harvard Medical School (HMS and HSDM) | Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation | 12/30 | 12/30 | | |
| xiao, WeiWei |
NCT04301557: PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer |
|
|
| Active, not recruiting | 2 | 25 | RoW | PD-1 Antibody, Toripalimab, Oxaliplatin, Capecitabine, External beam radiotherapy, Total mesorectal excision | Sun Yat-sen University | DMMR Colorectal Cancer, MSI-H Colorectal Cancer, Locally Advanced Colorectal Cancer | 04/24 | 12/24 | | |
NCT05060471: PD-1 Blockade Combined with Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients |
|
|
| Completed | 2 | 25 | RoW | Toripalimab, radiation | Sun Yat-sen University | Anal Canal Cancer, Anal Squamous Cell Carcinoma, Anal Cancer, Anal Canal Cancer Stage I, Anal Canal Cancer Stage II, Anal Canal Cancer Stage III | 06/24 | 11/24 | | |
| Active, not recruiting | 2 | 98 | RoW | Capecitabine, Oxaliplatin, External beam radiotherapy, Surgery, Watch and wait strategy | Sun Yat-sen University | Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III, Chemoradiation | 12/23 | 06/27 | | |
NCT05980689: Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 33 | RoW | AK104, Cadonilimab, Capecitabine, Neoadjuvant Radiotherapy | Sun Yat-sen University, Akeso, Haplox Biotechnology Co., Ltd. | Locally Advanced Rectal Cancer | 06/24 | 01/25 | | |
| Recruiting | 2 | 33 | RoW | Crisaborole Ointment, Cetuximab | Sun Yat-sen University | Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity | 12/24 | 12/25 | | |
B2024-585-01, NCT06764680: Oral Chemotherapy, Targeted Therapy and Immunotherapy With/without Radiotherapy As 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer |
|
|
| Not yet recruiting | 2 | 57 | RoW | Trifluorouracil tepidopyrimidine, Bevacizumab, Sindilizumab, IMRT | Sun Yat-sen University | Colorectal Cancer Metastatic, Chemotherapy, Targeted Therapy, Immunotherapy, Radiotherapy, Intensity-Modulated | 06/26 | 12/26 | | |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
NCT05969938: Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology |
|
|
| Recruiting | N/A | 50 | RoW | MRD detection | WeiWei Xiao, Haplox Biotechnology Co., Ltd. | Rectal Adenocarcinoma, Circulating Tumor DNA, Minimal Residual Disease, Neoadjuvant Chemoradiotherapy | 06/24 | 08/24 | | |
NCT06736678: Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients |
|
|
| Recruiting | N/A | 98 | RoW | Oral Immunonutrition | Sun Yat-sen University | Pancreatic Cancer, Neoadjuvant Chemoradiotherapy, Immunonutrition | 06/25 | 09/25 | | |
| Chen, Jiali |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Zeng, Zhifan |
NCT04301557: PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer |
|
|
| Active, not recruiting | 2 | 25 | RoW | PD-1 Antibody, Toripalimab, Oxaliplatin, Capecitabine, External beam radiotherapy, Total mesorectal excision | Sun Yat-sen University | DMMR Colorectal Cancer, MSI-H Colorectal Cancer, Locally Advanced Colorectal Cancer | 04/24 | 12/24 | | |
NCT05060471: PD-1 Blockade Combined with Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients |
|
|
| Completed | 2 | 25 | RoW | Toripalimab, radiation | Sun Yat-sen University | Anal Canal Cancer, Anal Squamous Cell Carcinoma, Anal Cancer, Anal Canal Cancer Stage I, Anal Canal Cancer Stage II, Anal Canal Cancer Stage III | 06/24 | 11/24 | | |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Wang, Fulong |
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis |
|
|
| Recruiting | 3 | 688 | RoW | Radical colectomy, HIPEC, Systemic chemotherapy | Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University | Colorectal Cancer | 04/24 | 04/26 | | |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Wu, Xiaojun |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Zhang, Rongxin |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Fang, Yujing |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Peng, Jianhong |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Ou, Qingjian |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
| Lu, Zhenhai |
NCT05228431: Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 121 | RoW | XELOX, Capecitabine monotherapy, Radiation | Zhen-Hai Lu | Advanced Rectal Cancer | 05/27 | 05/28 | | |
